Research Directory

How genome editing is impacting cell therapy

Read more

Building a European capital market

Read more

The new complexity in clinical study protocols

Read more

Why pharma is paying a premium for assets

Read more

Takeovers refocus Sanofi on rare diseases

Read more

How GMO rules affect gene and cell therapies

Read more

The case for optimism for Europe's biotech sector

Read more

The three waves of gene therapy

Read more

Building multifunctional biologics to treat disease

Read more

Novel immunotherapy arises from collaboration

Read more